Patient Experience Data in Radiation Oncology
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Medical University of Vienna
- Enrollment
- 6,000
- Locations
- 1
- Primary Endpoint
- radiation-related side effects
Study Overview
Brief Summary
The project is part of the overarching goal of improving patient-centric radiation oncology. This pilot project aims to develop an instrument that can be used to collect clinically relevant patient-reported outcome data on adverse effects during and after RT. This real-world evidence (RWE) database will be the basis to monitor and evaluate future technological developments, combination treatments (e.g. radioimmunotherapy, etc.), or changes in treatment protocols. The pseudonymized data will be linked to data in the oncological information system and dosimetric data from the treatment planning system. In this way, they represent a basic building block of patient-oriented development of clinical radiotherapy.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 100 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •all patients receiving external beam radiotherapy
Exclusion Criteria
- •unable to independently answer questionnaires on radiation-induced side effects
Outcomes
Primary Outcomes
radiation-related side effects
Time Frame: during radiotherapy and after (up until 5 years)
Secondary Outcomes
No secondary outcomes reported
Investigators
Gerd Heilemann
Principal Investigator
Medical University of Vienna